US equities |
META $630.56 ▲+0.00% MU $903.70 ▲+0.00% TSLA $391.62 ▲+0.00% NVDA $216.00 ▲+0.00% SPCX $146.90 ▲+0.00% SNDK $1,255.58 ▲+0.00% INTC $90.47 ▲+0.00% AMD $531.28 ▲+0.00%
FinancialContent

Fractyl Health, Inc. - Common Stock (NQ:GUTS)

1.070 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Fractyl Health, Inc. - Common Stock

< Previous 1 2 3 Next >
Unusual Volume Stocks: PRSO, SHFS, AHT Lead Today's Session ↗
Via Chartmill
Unusual Volume Standouts in the Latest Session ↗
Via Chartmill
Top Movers in Today's US Session: Biggest Gainers and Losers ↗
Via Chartmill
Top US Stock Gainers and Losers in Today's Session ↗
Via Chartmill
US Gap-Up and Gap-Down Stocks in the October 16, 2026 Session ↗
Via Chartmill
Fractyl Health Inc (NASDAQ:GUTS) Q1 Earnings: Net Income Swing Masks Core Operating Burn as Key Revita Data Readout Looms ↗
Via Chartmill
Fractyl Health (NASDAQ:GUTS) Posts Narrower-Than-Expected Loss Ahead of Pivotal Trial Readout ↗
Via Chartmill
News headline image
Earnings Scheduled For November 12, 2025 ↗
 
Via Benzinga
These stocks that are showing activity before the opening bell on Friday. ↗
Via Chartmill
What's going on in today's after hours session ↗
Via Chartmill
News headline image
Fractyl Health Eyes 2028 Revita Launch for Post-GLP-1 Weight Maintenance ↗
Fractyl Health (NASDAQ:GUTS) outlined a commercial strategy for its investigational Revita procedure, positioning the one-time endoscopic therapy as a potential option for patients seeking to maintain... 
Via MarketBeat
News headline image
Fractyl Health Eyes Q4 Revita Data, Launches Rejuva Gene Therapy Trial ↗
Fractyl Health (NASDAQ:GUTS) is advancing two one-time treatment approaches intended to provide durable benefits for obesity, type 2 diabetes and related metabolic diseases, Chief Executive Officer... 
Via MarketBeat
GUTS Stock Rallied About 28% Today – Here’s Why ↗
Via Stocktwits
News headline image
Fractyl Health Q2 Earnings Call Highlights ↗
Fractyl Health (NASDAQ:GUTS) said its Revita endoscopic procedure showed durable weight-maintenance results one year after patients discontinued GLP-1 therapy, while the company reaffirmed plans to... 
Via MarketBeat
Topics Earnings
These stocks are moving in today's session ↗
Via Chartmill
News headline image
Fractyl Health Says Revita Helped Patients Keep Weight Off After Stopping GLP-1s ↗
Fractyl Health (NASDAQ:GUTS) reported one-year data from the randomized midpoint cohort of its REMAIN-1 study, saying its Revita procedure helped patients maintain a larger share of GLP-1-induced... 
Via MarketBeat
News headline image
Fractyl Health Q1 Earnings Call Highlights ↗
Fractyl Health (NASDAQ:GUTS) said it remains on track to report pivotal data for its Revita therapy in early fourth quarter 2026, as management highlighted clinical, regulatory and reimbursement... 
Via MarketBeat
Topics Earnings
What's going on in today's after hours session ↗
Via Chartmill
Top movers in Thursday's session ↗
Via Chartmill
Curious about the most active stocks on Thursday? ↗
Via Chartmill
Keep an eye on the top gainers and losers in Thursday's session. ↗
Via Chartmill
Thursday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Why Did GUTS Stock Plummet Today Despite Positive Gut Therapy Midterm Study? ↗
Six-month data from 40 participants suggest that Revita helps limit weight regain after GLP-1 discontinuation. 
Via Stocktwits
These stocks that are showing activity before the opening bell on Thursday. ↗
Via Chartmill
News headline image
Fractyl Health&#39;s Revita Procedure Helps Patients Keep Weight Off After Stopping GLP-1 Drugs ↗
Fractyl Health (NASDAQ: GUTS) released positive 6-month results from its REVEAL-1 study in obese patients who discontinued GLP-1 therapy. 
Via Benzinga
News headline image
Fractyl (GUTS) Q3 2025 Earnings Call Transcript ↗
Fractyl (GUTS) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Preview: Fractyl Health's Earnings ↗
 
Via Benzinga
News headline image
Unusual volume stocks are being observed in Wednesday's session. ↗
Discover the stocks with unexpected trading volume in today's session on the US markets. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million. 
Via Benzinga
News headline image
What's going on in today's pre-market session ↗
Discover the top movers in Friday's pre-market session and stay informed about market dynamics. 
Via Chartmill
< Previous 1 2 3 Next >